期刊
JOURNAL OF ADVANCED RESEARCH
卷 6, 期 3, 页码 301-310出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jare.2014.11.004
关键词
HCV; Direct antiviral agents (DAA); Protease inhibitors; Polymerase inhibitors
The pegylated interferon regimen has long been the lone effective management of chronic hepatitis C with modest response. The first appearance of protease inhibitors included boceprevir and telaprevir. However, their efficacy was limited to genotype 1. Recently, direct antiviral agents opened the gate for a real effective management of HCV, certainly after FDA approval of some compounds that further paved the way for the appearance of enormous potent direct antiviral agents that may achieve successful eradication of HCV. (C) 2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据